Skip to main content
Malin Corporation Plc logo

Malin Corporation Plc — Investor Relations & Filings

Ticker · MLC ISIN · IE00BVGC3741 LEI · 635400JG4YSDU5U1YU17 IR Financial and insurance activities
Open in API
Filings indexed 180 across all filing types
Latest filing 2021-01-18 Regulatory Filings
Country IE Ireland
Listing IR MLC

About Malin Corporation Plc

http://malinplc.com/

Malin Corporation Plc is an investment company that provides long-term capital and operational expertise to highly innovative life sciences companies. The company focuses on private businesses operating in the therapeutics, medical devices, and diagnostics sectors. Its investment strategy is concentrated on specific therapeutic areas, primarily oncology, immunology, and genetic diseases. Malin supports its portfolio companies across various stages of development, from initial science and discovery through to clinical and commercial phases, with the objective of fostering the development of transformative technologies and outcomes for patients.

Recent filings

Filing Released Lang Actions
Immunocore Files for Potential IPO on Nasdaq
Regulatory Filings Classification · 99% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content announces that Malin Corporation's investee company, Immunocore, has filed a Form F-1 registration statement with the SEC for a proposed IPO. This is a general regulatory announcement concerning a significant corporate event (an IPO filing by an investee) that does not fit into the more specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS). Since it is a general regulatory announcement distributed via RNS and doesn't fit a more precise category, the appropriate classification is Regulatory Filings (RNS). The document length is relatively short (4595 chars), but it is reporting the *filing* itself, not just announcing the publication of a report, making RNS more suitable than RPA.
2021-01-18 English
Notice of EGM
AGM Information Classification · 98% confidence The document explicitly states it is a "Notice of Extraordinary General Meeting" and details the date, time, and purpose of the EGM, which involves considering and approving resolutions. This type of announcement, concerning a shareholder meeting, aligns directly with the definition of AGM Information (AGM-R), even though it specifies an 'Extraordinary' meeting rather than the standard 'Annual' one. Since the core function is announcing the meeting details and materials (Circular, Proxy Form), AGM-R is the most appropriate classification over a general Regulatory Filing (RNS). The document length is moderate (5057 chars), but the content is focused on the meeting notice itself, not just announcing a report's availability.
2021-01-15 English
Immunocore closes $75m Series C Financing
Capital/Financing Update Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a formal announcement dated January 11, 2021, regarding an investee company (Immunocore) completing a Series C Financing round and securing a loan facility. This is a typical corporate news release disseminated via the Regulatory News Service (RNS) of the London Stock Exchange. Since the content is a specific announcement about financing/capital activity (Series C completion and loan facility), it strongly aligns with the 'Capital/Financing Update' definition (CAP). Although it is distributed via RNS, the specific nature of the news (financing) makes CAP a more precise classification than the general fallback RNS.
2021-01-11 English
Kymab to be acquired by Sanofi
M&A Activity Classification · 99% confidence The document starts with an 'RNS Number' and is dated 11 January 2021. It announces a significant corporate event: Malin Corporation's investee company, Kymab, is being acquired by Sanofi. The text details the financial consideration, expected proceeds for Malin, plans for debt repayment, and initiation of capital returns to shareholders. It explicitly states, 'This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) No 596/2014 (MAR).' The presence of the RNS header and the nature of the announcement (a material corporate event disclosure) strongly indicate this is a regulatory news service release. Since it is a general, material announcement that doesn't fit perfectly into specific categories like M&A (TAR) or Capital Change (CAP) but is clearly a regulatory disclosure distributed via RNS, the most appropriate general regulatory filing category is RNS.
2021-01-11 English
Update from CEO
Regulatory Filings Classification · 99% confidence The document is very short (2890 characters) and explicitly states that it is publishing an 'Open Letter to Shareholders from the Chief Executive Officer' and provides a direct link to the PDF document. This structure—announcing the availability of a specific piece of content rather than containing the full content itself—fits the definition of a Report Publication Announcement (RPA). While it is a regulatory filing (indicated by the RNS Number and RNS distribution footer), RPA is more specific for announcements about published reports/letters. It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER).
2020-12-21 English
Mycovia Reports Positive Topline Results
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number' and contains a press release format announcing positive clinical trial results for a drug candidate (oteseconazole) developed by an investee company (Mycovia/Viamet). The announcement is dated December 9, 2020, and is distributed via RNS, the news service of the London Stock Exchange. This type of announcement, which relays material, non-financial, or general corporate news that doesn't fit specific financial report categories (like 10-K, ER, or IR), is best classified as a general Regulatory Filing or announcement. Since it is a formal announcement distributed through the RNS system, and it is not a specific financial report, dividend notice, or management change, the most appropriate general category is Regulatory Filings (RNS). The document length is relatively short (4883 chars) and it points to an external press release, which aligns with the characteristics of an RNS announcement rather than the full report itself.
2020-12-09 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.